Insiders · TAK

Koichiro Kimura

Director at Takeda Pharmaceutical Co Ltd (TAK) since June 2026

Koichiro Kimura has filed 2 insider reports with the SEC since July 2026, as director at Takeda Pharmaceutical Co Ltd (TAK). The latest filing, on July 6, 2026, reports grant or award at Takeda Pharmaceutical Co Ltd (TAK).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Koichiro Kimura is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Takeda Pharmaceutical Co Ltd logo
TAK
Takeda Pharmaceutical Co Ltd
Directorsince June 20261,800$21.77Jul 6, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Koichiro Kimura with

Other insiders at the same companies

Questions about Koichiro Kimura

What is Koichiro Kimura's role at Takeda Pharmaceutical Co Ltd?
Koichiro Kimura reports to the SEC as director at Takeda Pharmaceutical Co Ltd (TAK), according to the latest filing on July 6, 2026.
How many shares does Koichiro Kimura own?
After the latest filing that states it, Koichiro Kimura directly owned 1,800 shares of Takeda Pharmaceutical Co Ltd (TAK). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Koichiro Kimura bought or sold stock recently?
No open-market purchases or sales by Koichiro Kimura are on file. The filings report grant or award.
How do I get alerts when Koichiro Kimura files?
Follow Koichiro Kimura on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Koichiro Kimura (SEC CIK 0002137620). Totals count each trade once, skipping amendments whose original is on file, from Jul 6, 2026 on. View on SEC EDGAR · Get this as JSON